GlycoMimetics (GLYC) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
Glycomimetics (GLYC) PT Lowered to $15 at Jefferies; Reiterates Buy
November 9, 2017 8:55 AM ESTJefferies lowered its price target on Glycomimetics (NASDAQ: GLYC) to $15.00 (from $16.00) while maintaining a Buy rating following the company's 3Q earnings report and pipeline update. GLYC reported GAAP EPS of ($0.24) vs consensus of ($0.28), reflecting lower R&D costs than previously... More
